World CDx Europe 2018

Meet with Q2 Solutions at World CDx Europe 2018 and learn how we can help you drive companion diagnostics and precision medicine forward

London, UK | May 01, 2018 - May 03, 2018 | 08:00 - 17:00 Add to Calendar
Register for presentation post-event Schedule a Meeting

About This Event

Employing a comprehensive suite of genomics expertise, molecular and protein-based platforms, Q2 Solutions’ end-to-end services can help you identify predictive biomarkers, develop and deploy diagnostic tests, and engage the most appropriate patient populations to demonstrate the safety and efficacy of your therapeutic products.

Our extensive precision medicine laboratory solutions span the development lifecycle to help you begin with biomarker identification programs early in development and then progressively develop candidate biomarkers into research-appropriate tests and market-ready companion diagnostics.

Q2 Solutions’ integrated and closely tailored approach provides you with an optimal path to co-develop your companion diagnostic (CDx) with clinical development of the therapeutic.

Make plans to attend Alan Wookey’s presentation at the World CDx Europe 2018 - our Global Science Lead for Companion Diagnostics & Oncology Science Advisor will be discussing Central Laboratory Considerations for Deploying a Global Companion Diagnostics Solution on Conference Day Two – Thursday, May 3rd, at 9:30 am. Some key points his presentation will be touching upon are:
  • How Traditional technologies and Next Generation Sequencing are being used for Companion Diagnostics.
  • Considerations for implementing a global CDx program using NGS.
  • Potential Regulatory and Commercialization paths for NGS approval for a Companion Diagnostic.

Schedule a meeting with us at this year’s World CDx Europe to learn how we can help you maximize your companion diagnostic strategy.

We look forward to meeting you in London.

Related Services:

Register for Event

Companion Diagnostic Expertise

Learn how we can ensure success in your next companion diagnostic development program

Q2 Solutions Biomarker Services

Providing tools and experience to maximize your biomarker strategy

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Companion Diagnostic Development: Current trends and recommendations

Read More